A 55-year-old woman with bony metastatic breast cancer was commenced on daily ibandronic acid to prevent skeletal related events (SREs). Four years later, she began to experience new lower limb and groin pain with investigations leading to the suspicion of further metastatic spread to her left femur. While awaiting radiotherapy for this, she unfortunately tripped and fell sustaining a fracture to the proximal third of her left femur. Radiographic findings of her femur from both before and after the fall were suggestive of an atypical femoral fracture, presumed secondary to her bisphosphonate therapy rather than metastatic spread.

manages Digital Harbor Foundation's research initiatives, program evaluation processes, grant development, and fundraising initiatives. Adena formerly worked as a Researcher for the Wom-anStats Project studying violence against women, the Woodrow Wilson International Center for Scholars studying the 2011 Arab Uprisings, and Brigham Young University's Political Science Department studying marriage and family practices of the Middle East. She graduated with a Bachelor's Degree in Middle Eastern Studies and Arabic from Brigham Young University where she received the Middle East Studies/Arabic Student Research Award in April 2017. Shawn Grimes, Unaffiliated Shawn Grimes has nearly 20 years of experience as a technologist in a variety of fields including mobile app development, cyber security, and software engineering. Through his passion for working with and serving youth, he served as the Director of Technology at the Digital Harbor Foundation where their work focused on teaching technology and maker skills to youth.

No abstract

No abstract

The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.